MedTrace Logo

Evaluation of the Applicability and Reliability of the Three Meter Backwalk Test in Children With Cerebral Palsy (CP)

NCT04653363 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 80

Last updated 2021-11-23

No results posted yet for this study

Summary

Cerebral palsy (CP) is a non-progressive disturbance in the development of movement and posture that occurs in the prenatal or postnatal period, causing activity limitations. Most children and adolescents with CP experience limitations in their walking skills. Restrictions in the walking ability of children with CP are an important issue for both parents and healthcare professionals involved in their treatment.

The evaluation of walking is of great importance in terms of determining the effectiveness of the physiotherapy program, shaping the program, planning orthopedic and surgical applications, and determining the effectiveness, especially in children with CP who have walking potential. In the literature, easy-to-use, valid and reliable observational gait analysis that can evaluate gait pathologies and clinical gait in children with CP are emphasized. These measurements are of great importance in clinical practice.The ability of backward walking gives the child a different task than normal, allowing the observation of body perception, trunk stability provided by anterior-posterior co-contractions, balance, correction and protective reactions.

Conditions

  • Cerebral Palsy
  • Cerebral Palsy Spastic Diplegia
  • Hemiplegic Cerebral Palsy
  • Gait, Hemiplegic
  • Gait, Spastic

Interventions

OTHER

assessments

All assesments will be done by the first physiotherapist. But only 3m backward test will be done by the first and second physiotherapist in the first day and second day.

Sponsors & Collaborators

  • Sanko University

    lead OTHER

Principal Investigators

  • hatice adıgüzel, PhD · sanko Üniversitesi

Eligibility

Min Age
8 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-12-15
Primary Completion
2021-11-01
Completion
2021-11-19

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04653363 on ClinicalTrials.gov